Body doubling

Last updated

Body doubling or parallel working [1] is a strategy used to initiate and complete tasks, such as household chores or writing and other computer tasks. [2] It involves the physical presence, virtual presence through a phone call, videotelephony or social media presence, [2] [3] of someone with whom one shares their goals, which makes it more likely to achieve them. [1] For some people, it works best to both do similar tasks, while for others, just being in the same (virtual) room is enough. [2]

Contents

It was partially popularized by those with Attention deficit hyperactivity disorder (ADHD) to help manage symptoms. [4] Its usefulness has also been noted by those with autism, [2] but efficacy is not clearly known as long term studies have not been conducted on the topic. [2] In 2023, J. Russel Ramsay, professor of clinical psychiatry at the Perelman School of Medicine and co-director of the ADHD treatment and research program of the University of Pennsylvania, noted that, while extensive research on the strategy's effect on productivity doesn't exist, "the idea of externalizing motivation is a longstanding evidence-based mechanism for managing ADHD." [4]

ADHD body doubling comes into play allowing individuals with ADHD to perform and complete tasks easier and with less distractions, where otherwise they might struggle more. "ADHD body doubling is a productivity strategy used by individuals with ADHD to finish possibly annoying jobs while having another person beside them." [5]

Body doubling is said to aid individuals with focus and productivity while working. Another person, known as a 'body double' sits alongside the individual with ADHD to help them focus while completing a certain task. [6] The role of this individual is to not partake in the task but, more importantly, serve as a support system and create a welcoming environment that allows the individual to focus by reducing any distractions. The idea of body doubling allows for specific reminders to the individual to stay on task which helps alleviate the symptoms of ADHD. [4]

History

The notion of body doubling derives from the cognitive behavioral therapy (CBT) techniques which focus on assisting those with cognitive disorders.[ citation needed ] Body doubling was first used to alleviate anxiety and improve concentration; recently, it has gained popularity as a way to promote concentration in multiple settings such as schools, home-working environments, and occupations. [6] [ failed verification ] Typically, in the 20th century, treatments for ADHD include methylphenidate (Ritalin) and amphetamine mixtures (Adderall). [7]

However, recent studies suggest that body doubling could be a viable alternative rather than the widely used medications. [5] Additionally, individuals with ADHD oftentimes have educational accommodations such as extra time on exams, preferred seating, and breaking down tasks into various steps. The concept of body doubling has been recognized as a new viable option for these pre-existing accommodations. [5] The concept of having an individual close by to provide clear guidance and encouragement will allow the individual with ADHD to stay focused on a particular task should they be partaking in more than one task. It is important that the body double does not distract the other person with conversation or anything else. [4]

Methodology

The individual and body double list specific tasks that they want to complete in a certain amount of time. The body double does not necessarily need to sit shoulder to shoulder with the individual but should provide a calming, nurturing, and quiet presence.  The individual is advised not to switch tasks and solely stay focused and work on the task that was assigned. [5]

Some benefits of body doubling include increasing the individual's accountability, less feelings of isolation, and an increase in motivation. [8] It allows for subtle reinforcement to prevent procrastination and create consistency towards their goals. According to one director of an ADHD counseling practice, "The idea is that the presence of another is essentially a gentle reminder to stay on task (...) For folks (with) ADHD whose minds tend to wander and get off task, the body double somehow works as an external motivator to stay on task." [4]  Most importantly, the body double creates a safe and accepting environment where the individual feels the symptoms of ADHD much less; such as criticism or failure. [9]

Applications

Body doubling is not used solely for individuals with ADHD. It is now widely used as part of therapeutic settings to assist individuals with autism, anxiety disorders, and other conditions influenced by functioning deficits. [4]

This concept is not structured solely for students but for professionals and any individuals who are looking to enhance and optimize their performance. Asking for and applying a body double may come across as awkward however, one could say, "It's something I heard can help with productivity. Would you mind just being around me while I work on this? Maybe you have something you could work on, too." [4]

Examples of body doubling could include someone asking a person to be on Zoom while they work on something, doing chores while on a phone with their friend, or joining a study group while preparing for a test. [9]

Criticism and limitations

While body doubling has been seen as an effective tool for alleviating the symptoms of ADHD, many factors come into play in determining whether it is as effective as it is said to be. A variety of factors such as personality types, individual preferences, and the types of tasks at hand can influence the effectiveness of body doubling. Additionally, relying solely on a body double to complete tasks may impact the individual's ability to develop individual working and coping strategies in the future.[ citation needed ] It is important and necessary for the individual to balance between individual and body double work. [8] [ failed verification ]

See also

Related Research Articles

<span class="mw-page-title-main">Modafinil</span> Eugeroic medication

Modafinil, sold under the brand name Provigil among others, is a wakefulness-promoting medication used primarily to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks. Modafinil is also approved for stimulating wakefulness in people with sleep apnea and shift work sleep disorder. It is taken by mouth. Modafinil is not approved by the US Food and Drug Administration (FDA) for use in people under 17 years old.

<span class="mw-page-title-main">Attention deficit hyperactivity disorder</span> Neurodevelopmental disorder

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and otherwise age-inappropriate.

<span class="mw-page-title-main">Stimulant</span> Drug that increases activity of central nervous system

Stimulants are a class of drugs that increase the activity of the brain. They are used for various purposes, such as enhancing alertness, attention, motivation, cognition, mood, and physical performance. Some of the most common stimulants are caffeine, nicotine, amphetamines, cocaine, methylphenidate, and modafinil.

<span class="mw-page-title-main">Methylphenidate</span> Central nervous system stimulant

Methylphenidate, sold under the brand names Ritalin and Concerta among others, is a potent central nervous system (CNS) stimulant used medically to treat attention deficit hyperactivity disorder (ADHD) and, to a lesser extent, narcolepsy. It is a primary medication for ADHD ; it may be taken by mouth or applied to the skin, and different formulations have varying durations of effect. For ADHD, the effectiveness of methylphenidate is comparable to atomoxetine but modestly lower than amphetamines, alleviating the executive functioning deficits of sustained attention, inhibition, working memory, reaction time and emotional self-regulation.

<span class="mw-page-title-main">Dextroamphetamine</span> CNS stimulant and isomer of amphetamine

Dextroamphetamine (INN:dexamfetamine) is a potent central nervous system (CNS) stimulant and enantiomer of amphetamine that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used as an athletic performance and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. Dextroamphetamine is generally regarded as the prototypical stimulant.

Developmental disorders comprise a group of psychiatric conditions originating in childhood that involve serious impairment in different areas. There are several ways of using this term. The most narrow concept is used in the category "Specific Disorders of Psychological Development" in the ICD-10. These disorders comprise developmental language disorder, learning disorders, developmental coordination disorders, and autism spectrum disorders (ASD). In broader definitions, attention deficit hyperactivity disorder (ADHD) is included, and the term used is neurodevelopmental disorders. Yet others include antisocial behavior and schizophrenia that begins in childhood and continues through life. However, these two latter conditions are not as stable as the other developmental disorders, and there is not the same evidence of a shared genetic liability.

<span class="mw-page-title-main">Adderall</span> Drug mixture used mainly to treat ADHD and narcolepsy

Adderall and Mydayis are trade names for a combination drug called mixed amphetamine salts containing four salts of amphetamine. The mixture is composed of equal parts racemic amphetamine and dextroamphetamine, which produces a (3:1) ratio between dextroamphetamine and levoamphetamine, the two enantiomers of amphetamine. In terms of base, rather than salts, the ratio is 3.15:1 for dextro- to levoamphetamine. Both enantiomers are stimulants, but differ enough to give Adderall an effects profile distinct from those of racemic amphetamine or dextroamphetamine, which are marketed as Evekeo and Dexedrine/Zenzedi, respectively. MAS is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used illicitly as an athletic performance enhancer, cognitive enhancer, appetite suppressant, and recreationally as a euphoriant. It is a central nervous system (CNS) stimulant of the phenethylamine class.

<span class="mw-page-title-main">Dexmethylphenidate</span> CNS Stimulant

Dexmethylphenidate, sold under the brand name Focalin among others, is a potent central nervous system (CNS) stimulant used to treat attention deficit hyperactivity disorder (ADHD) in those over the age of five years. It is taken by mouth. The immediate release formulation lasts up to five hours while the extended release formulation lasts up to twelve hours. It is the more active enantiomer of methylphenidate.

<span class="mw-page-title-main">Hyperfocus</span> Intense form of mental concentration

Hyperfocus is an intense form of mental concentration or visualization that focuses consciousness on a subject, topic, or task. In some individuals, various subjects or topics may also include daydreams, concepts, fiction, the imagination, and other objects of the mind. Hyperfocus on a certain subject can cause side-tracking away from assigned or important tasks.

Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood. It is a neurodevelopmental disorder, meaning impairing symptoms must have been present in childhood, except for when ADHD occurs after traumatic brain injury. Specifically, multiple symptoms must be present before the age of 12, according to DSM-5 diagnostic criteria. The cutoff age of 12 is a change from the previous requirement of symptom onset, which was before the age of 7 in the DSM-IV. This was done to add flexibility in the diagnosis of adults. ADHD was previously thought to be a childhood disorder that improved with age, but recent research has disproved this. Approximately two-thirds of childhood cases of ADHD continue into adulthood, with varying degrees of symptom severity that change over time and continue to affect individuals with symptoms ranging from minor inconveniences to impairments in daily functioning.

Cognitive disengagement syndrome (CDS) is an attention syndrome characterised by prominent dreaminess, mental fogginess, hypoactivity, sluggishness, slow reaction time, staring frequently, inconsistent alertness, and a slow working speed. To scientists in the field, it has reached the threshold of evidence and recognition as a distinct syndrome.

Attention deficit hyperactivity disorder predominantly inattentive, is one of the three presentations of attention deficit hyperactivity disorder (ADHD). In 1987–1994, there were no subtypes or presentations and thus it was not distinguished from hyperactive ADHD in the Diagnostic and Statistical Manual (DSM-III-R). In DSM-5, subtypes were discarded and reclassified as presentations of the same disorder that change over time.

<span class="mw-page-title-main">Attention deficit hyperactivity disorder controversies</span> Controversies surrounding the topic of ADHDs nature, diagnosis, and treatment

Despite the scientifically well-established nature of attention deficit hyperactivity disorder (ADHD), its diagnosis, and its treatment, each of these has been controversial since the 1970s. The controversies involve clinicians, teachers, policymakers, parents, and the media. Positions range from the view that ADHD is within the normal range of behavior to the hypothesis that ADHD is a genetic condition. Other areas of controversy include the use of stimulant medications in children, the method of diagnosis, and the possibility of overdiagnosis. In 2009, the National Institute for Health and Care Excellence, while acknowledging the controversy, stated that the current treatments and methods of diagnosis are based on the dominant view of the academic literature.

Tourette syndrome is an inherited neurodevelopmental disorder that begins in childhood or adolescence, characterized by the presence of motor and phonic tics. The management of Tourette syndrome has the goal of managing symptoms to achieve optimum functioning, rather than eliminating symptoms; not all persons with Tourette's require treatment, and there is no cure or universally effective medication. Explanation and reassurance alone are often sufficient treatment; education is an important part of any treatment plan.

<span class="mw-page-title-main">Trace amine</span> Amine receptors in the mammalian brain

Trace amines are an endogenous group of trace amine-associated receptor 1 (TAAR1) agonists – and hence, monoaminergic neuromodulators – that are structurally and metabolically related to classical monoamine neurotransmitters. Compared to the classical monoamines, they are present in trace concentrations. They are distributed heterogeneously throughout the mammalian brain and peripheral nervous tissues and exhibit high rates of metabolism. Although they can be synthesized within parent monoamine neurotransmitter systems, there is evidence that suggests that some of them may comprise their own independent neurotransmitter systems.

<span class="mw-page-title-main">Lisdexamfetamine</span> Central nervous system stimulant prodrug

Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. Lisdexamfetamine is taken by mouth. Its effects generally begin within two hours and last for up to 14 hours. In the United Kingdom, it is usually less preferred to methylphenidate for the treatment of children.

Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD. Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training, neurofeedback, neurostimulation, physical exercise, nutrition and supplements, integrative medicine, parent support, and school interventions. Based on a systematic literature review and meta analysis conducted in 2024, only FDA-approved medications and psychosocial interventions have been shown to improve core ADHD symptoms compared to control groups.

In psychology and neuroscience, executive dysfunction, or executive function deficit, is a disruption to the efficacy of the executive functions, which is a group of cognitive processes that regulate, control, and manage other cognitive processes. Executive dysfunction can refer to both neurocognitive deficits and behavioural symptoms. It is implicated in numerous psychopathologies and mental disorders, as well as short-term and long-term changes in non-clinical executive control. Executive dysfunction is the mechanism underlying ADHD paralysis, and in a broader context, it can encompass other cognitive difficulties like planning, organizing, initiating tasks and regulating emotions. It is a core characteristic of ADHD and can elucidate numerous other recognized symptoms.

Virginia I. Douglas was a Canadian psychologist. She was a professor at McGill University in Montreal, Canada, noted for her contributions to the study of attention deficit hyperactivity disorder (ADHD).

The ADHD Rating Scale (ADHD-RS) is a parent-report or teacher-report inventory created by George J. DuPaul, Thomas J. Power, Arthur D. Anastopoulos, and Robert Reid consisting of 18–90 questions regarding a child's behavior over the past 6 months. The ADHD Rating Scale is used to aid in the diagnosis of attention deficit hyperactivity disorder (ADHD) in children ranging from ages 5–17.

References

  1. 1 2 Berger, Chloe (March 5, 2023). "Remote workers are adopting a new practice called 'body doubling,' in which they watch strangers work online". Fortune . Archived from the original on March 5, 2023. Retrieved February 14, 2024.
  2. 1 2 3 4 5 Broadwater, Ashley (February 7, 2023). "How 'Body Doubling' Can Help You Start And Complete Tasks". HuffPost . Archived from the original on February 14, 2024. Retrieved February 14, 2024.
  3. ↑ Quinn, Patricia (December 28, 2022). "Get More Done with a Body Double". ADDitude . Archived from the original on February 5, 2024. Retrieved February 14, 2024.
  4. 1 2 3 4 5 6 7 Rogers, Kristen (February 13, 2023). "The benefits of 'body doubling' when you have ADHD, according to experts". CNN Health . Archived from the original on February 4, 2024. Retrieved February 14, 2024.
  5. 1 2 3 4 "The Body Double: A Unique Tool for Getting Things Done". ADDA - Attention Deficit Disorder Association. October 24, 2022. Retrieved April 16, 2024.
  6. 1 2 Lovering, Nancy (May 11, 2022). "ADHD Body Doublin". Psych Central. Retrieved April 16, 2024.
  7. ↑ Connolly, JJ (2015). "ADHD & Pharmacotherapy: Past, Present and Future". Therapeutic Innovation & Regulatory Science. 49 (5): 632–642. doi:10.1177/2168479015599811. PMC   4564067 . PMID   26366330. The most common and effective medications are methylphenidates and amphetamines.
  8. 1 2 "Could a Body Double Help You Increase Your Productivity?". Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD). Retrieved April 16, 2024.
  9. 1 2 Kim, Donna (August 30, 2023). "Body doubling for ADHD: What it is and how it works". Understood. Retrieved April 16, 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.